HomeHALO • NASDAQ
Halozyme Therapeutics, Inc.
$40.77
Mar 28, 11:08:39 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$40.73
Day range
$40.44 - $40.89
Year range
$29.85 - $45.00
Market cap
5.18B USD
Avg Volume
1.11M
P/E ratio
19.43
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
230.04M26.75%
Operating expense
52.87M159.15%
Net income
85.39M47.98%
Net profit margin
37.1216.77%
Earnings per share
0.8270.83%
EBITDA
122.93M20.25%
Effective tax rate
15.60%—
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
336.00M-7.39%
Total assets
1.73B-5.88%
Total liabilities
1.65B-1.33%
Total equity
83.81M—
Shares outstanding
126.82M—
Price to book
61.71—
Return on assets
14.28%—
Return on capital
15.25%—
Net change in cash
(USD)Dec 2023Y/Y change
Net income
85.39M47.98%
Cash from operations
102.35M24.14%
Cash from investing
-8.29M-374.86%
Cash from financing
-249.92M-4,048.81%
Net change in cash
-155.86M-279.07%
Free cash flow
71.00M-31.35%
About
Halozyme Therapeutics is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Founded
1998
Employees
373
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu